EMG
AIMT

Ellington Management Group’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Ellington Management Group’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-9,400
Closed -$299K – 964
2018
Q1 		$299K Buy
+9,400
New +$299K 0.02% 588